Participants to Advanced Liver Cancer Study, Wanted by Moffitt
The Moffitt Cancer Center in Tampa, Florida is seeking patients who have primary liver cancer (hepatocellular carcinoma) that has spread to other organs or is too advanced to be treated by surgery and must have had prior chemotherapy treatments.
The said patients are being recruited by Moffitt for the phase II study of the oral medication AZD6244 — an experimental anti-cancer drug that may stop the growth of cancer cells and is designed to block the pathway of a protein called MEK (important for cell survival).
According to Dr. Chris R. Garrett, principal investigator with Moffitt’s Gastrointestinal Oncology program:
“There’s no cure for advanced liver cancer that’s not amenable to surgery. We’re looking for a novel therapy to improve the outcome for patients with the disease.”
The said trial - also being conducted at Emory University, The University of North Carolina at Chapel Hill, Vanderbilt University and VCU Massey Cancer Center - is sponsored by The National Cancer Institute.
If you qualify as a participant or you someone who does, you can call clinical research nurse Tiffany Campos at (813) 745-8358.
Source: Moffitt Cancer Center
Tags: AZD6244, hepatocellular-carcinoma, Moffitt-Cancer-CenterRelated Stories
POSTED IN: on anti-cancer ingredients, on liver cancer
0 opinions for Participants to Advanced Liver Cancer Study, Wanted by Moffitt
No one has left a comment yet. You know what this means, right? You could be first!
Have an opinion? Leave a comment: